An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer
Source abstract
Abstract
Multiple sclerosis (MS) is characterized by the presence of inflammatory demyelinating foci throughout the brain and spinal cord, accompanied by axonal and neuronal damage. Although inflammatory processes are thought to underlie the pathological changes, the individual mediators of this damage are unclear. In order to study the role of pro-inflammatory cytokines in demyelination in the central nervous system, we have utilized a hyperbranched poly(2-dimethyl-aminoethylmethacrylate) based non-viral gene transfection system to establish an inflammatory demyelinating model of MS in an ex-vivo environment. The synthesized non-viral gene transfection system was optimized for efficient transfection with minimal cytotoxicity. Organotypic brain slices were then successfully transfected with the TNF or IFNγ genes. TNF and IFNγ expression and release in cerebellar slices via non-viral gene delivery approach resulted in inflammation mediated myelin loss, thus making it a promising ex-vivo approach for studying the underlying mechanisms of demyelination in myelin-related diseases such as MS.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Multiple Sclerosis Research Studies · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. Multiple sclerosis10.1016/S0140-6736(08)61620-7 ↗
2. The neuropathological basis of clinical progression in multiple sclerosis10.1007/s00401-011-0840-0 ↗
3. Animal models of multiple sclerosis for the development and validation of novel therapies – potential and limitations
4. Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis10.1016/j.it.2005.08.014 ↗
5. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research10.1093/brain/awl075 ↗
6. Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis10.1016/S0002-9440(10)63232-4 ↗
7. A new focal EAE model of cortical demyelination: multiple sclerosis-like lesions with rapid resolution of inflammation and extensive remyelination10.1093/brain/awl135 ↗
8. Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera10.1016/0022-510X(84)90092-3 ↗
9. Studies on demyelination in vitro: the requirement of membrane attack components of the complement system10.4049/jimmunol.131.2.778 ↗
10. In vitro modeling of central nervous system myelination and remyelination10.1002/glia.21231 ↗
11. Retinoid X receptor gamma signaling accelerates CNS remyelination10.1038/nn.2702 ↗
12. A gradient of neuronal loss and meningeal inflammation in multiple sclerosis10.1002/ana.22230 ↗
13. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis10.1093/brain/awr182 ↗
14. Interferon-gamma potentiates antibody-mediated demyelination in vivo10.1002/ana.410320212 ↗
15. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease
16. Vaccinia virus transfection of hippocampal slice neurons10.1016/0896-6273(95)90212-0 ↗
17. Adeno-associated viral vector-mediated gene transduction in mesencephalic slice culture10.1016/j.jneumeth.2011.07.010 ↗
18. Gene transfer methods for CNS organotypic cultures: a comparison of three nonviral methods10.1006/mthe.2000.0235 ↗
19. High-efficiency transfection of individual neurons using modified electrophysiology techniques10.1016/S0165-0270(03)00069-4 ↗
20. Optimized protocol for biolistic transfection of brain slices and dissociated cultured neurons with a hand-held gene gun10.1016/S0165-0270(99)00094-1 ↗
21. Biolistic delivery of voltage-sensitive dyes for fast recording of membrane potential changes in individual neurons in rat brain slices10.1016/j.jneumeth.2012.09.008 ↗
22. Construction and application of a microprojectile system for the transfection of organotypic brain slices10.1016/S0165-0270(00)00269-7 ↗
23. Progress and problems with the use of viral vectors for gene therapy10.1038/nrg1066 ↗
24. Gene transfer to rabbit retina with electron avalanche transfection10.1167/iovs.06-0092 ↗
25. Hyperbranched PEGmethacrylate linear pDMAEMA block copolymer as an efficient non-viral gene delivery vector10.1016/j.ijpharm.2012.05.010 ↗
26. Identification of calcium channels involved in neuronal injury in rat hippocampal slices subjected to oxygen and glucose deprivation10.1016/S0006-8993(96)01385-6 ↗
27. A new mathematical model for relative quantification in real-time RT-PCR10.1093/nar/29.9.e45 ↗
28. Recent advances in quantitative colocalization analysis: focus on neuroscience10.1016/j.proghi.2009.03.001 ↗
29. Biophysical stimulation induces demyelination via an integrin-dependent mechanism10.1002/ana.23592 ↗
30. Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon10.1038/sj.gt.3300743 ↗
31. Toxic effects of lipid-mediated gene transfer in ventral mesencephalic explant cultures10.1111/j.1742-7843.2006.pto_310.x ↗
32. Markers for neuronal degeneration in organotypic slice cultures10.1016/S1385-299X(98)00050-6 ↗
33. Lysolecithin induces demyelination in vitro in a cerebellar slice culture system10.1002/jnr.20248 ↗
34. Central nervous system remyelination in culture – a tool for multiple sclerosis research10.1016/j.expneurol.2011.04.009 ↗
35. Liposomes for use in gene delivery
36. FuGENE 6 transfection reagent: the gentle power10.1016/j.ymeth.2003.11.002 ↗
37. Evaluation of lipid-based reagents to mediate intracellular gene delivery10.1016/S0005-2736(02)00545-X ↗
38. Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: correlation with demyelinating activity and oligodendrocyte pathology10.1002/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO;2-Y ↗
39. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system10.1002/eji.1830270416 ↗
40. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization10.1016/S1043-4666(05)80008-0 ↗
41. Primary demyelination in transgenic mice expressing interferon-γ10.1038/nm0997-1037 ↗
42. Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage10.1016/j.expneurol.2008.12.027 ↗
43. Tumor necrosis factor-alfa and interleukin-4 in cerebrospinal fluid and plasma in different clinical forms of multiple sclerosis10.2298/VSP1202151O ↗
44. Profile of cerebrospinal fluid and serum cytokines in patients with relapsing-remitting multiple sclerosis. a correlation with clinical activity10.3109/08923979809034820 ↗
45. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?10.1111/j.1600-0404.1988.tb03663.x ↗
46. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and γ-IFN levels in serum and cerebrospinal fluid10.1016/0022-510X(89)90171-8 ↗
47. TNFα potentiates IFNγ-induced cell death in oligodendrocyte progenitors10.1002/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.0.CO;2-0 ↗
48. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms10.1002/ana.22551 ↗